バイオ・医療の業種の、上場・店頭(上櫃)の160社の月次売上を、売上の大きい順に並べています。業種の合計は333.9億台湾ドル(前年同月比 +10.8%)です。
| 順位 | 企業 | 売上高 (台湾ドル) | 前年 同月比 | 前月比 |
|---|---|---|---|---|
| 1 | 藥華藥 | 28.4億 | +102.0% | +7.6% |
| 2 | 美時 | 21.3億 | -22.5% | -22.8% |
| 3 | 保瑞 | 19.9億 | +15.9% | -14.4% |
| 4 | 大樹 | 16.7億 | +1.5% | +4.4% |
| 5 | 佳醫 | 10.2億 | +38.6% | +6.4% |
| 6 | 晶碩 | 7.9億 | +13.0% | +5.6% |
| 7 | 健喬 | 7.7億 | +41.2% | +2.6% |
| 8 | 永信 | 7.5億 | +4.4% | +13.7% |
| 9 | 葡萄王 | 7.5億 | -30.8% | +3.0% |
| 10 | 中化控股 | 7.5億 | +5.3% | +10.6% |
| 11 | 東洋 | 7.3億 | +36.5% | -20.2% |
| 12 | 杏一 | 7億 | +3.3% | +5.3% |
| 13 | 國光生 | 6.3億 | +6.7% | +104.8% |
| 14 | 生達 | 6.2億 | -3.5% | -11.5% |
| 15 | 聯合 | 5.6億 | +7.7% | +17.7% |
| 16 | 視陽 | 5.3億 | +60.0% | +6.6% |
| 17 | 大江 | 5.1億 | -19.4% | -2.4% |
| 18 | 台耀 | 5億 | +24.0% | +1.7% |
| 19 | 明基醫 | 4.4億 | +2.1% | +5.5% |
| 20 | 泰博 | 4.4億 | +53.9% | +10.4% |
| 21 | 寶島科 | 4.3億 | +14.7% | +16.0% |
| 22 | 友華 | 4.2億 | -4.2% | -3.6% |
| 23 | 杏昌 | 3.8億 | +1.4% | -8.7% |
| 24 | 大學光 | 3.8億 | +8.7% | +4.9% |
| 25 | 麗豐-KY | 3.7億 | +3.9% | -22.7% |
| 26 | 盛弘 | 3.6億 | -5.9% | -15.3% |
| 27 | 承業醫 | 3.5億 | +2.5% | -31.6% |
| 28 | 優盛 | 3.4億 | +10.2% | +4.2% |
| 29 | 望隼 | 3.3億 | -5.8% | -15.2% |
| 30 | 軒郁 | 3.3億 | +12.3% | +19.0% |
| 31 | 全宇生技-KY | 3.2億 | -2.0% | -12.1% |
| 32 | 諾貝兒 | 3.2億 | +1.1% | +2.0% |
| 33 | 杏輝 | 3億 | +8.2% | +16.3% |
| 34 | 佑全 | 2.8億 | +4.5% | +6.6% |
| 35 | 精華 | 2.8億 | -11.5% | -7.0% |
| 36 | 台康生技 | 2.7億 | +287.9% | +131.5% |
| 37 | 鐿鈦 | 2.5億 | +49.0% | +6.5% |
| 38 | 睿生光電 | 2.4億 | +4.1% | -19.9% |
| 39 | 太醫 | 2億 | -6.3% | -7.3% |
| 40 | 邦特 | 2億 | +2.4% | +2.7% |
| 41 | 南光 | 2億 | +6.6% | +23.5% |
| 42 | 雃博 | 2億 | -5.1% | -12.7% |
| 43 | 生展 | 1.9億 | +12.3% | -4.0% |
| 44 | 雙美 | 1.9億 | +18.2% | -20.3% |
| 45 | 合富-KY | 1.8億 | +12.5% | -46.9% |
| 46 | 久裕 | 1.8億 | +68.1% | +2.4% |
| 47 | 佐登-KY | 1.8億 | -1.5% | -6.7% |
| 48 | 中天 | 1.7億 | -3.1% | +12.7% |
| 49 | 東生華 | 1.7億 | +19.3% | -48.1% |
| 50 | 神隆 | 1.6億 | -47.4% | -47.2% |
| 51 | 美吾華 | 1.6億 | +21.1% | +14.5% |
| 52 | 寶齡富錦 | 1.6億 | +16.7% | +13.9% |
| 53 | 華廣 | 1.5億 | +12.2% | -14.4% |
| 54 | 訊映 | 1.5億 | +19.6% | -29.4% |
| 55 | 基亞 | 1.5億 | +6.6% | -40.6% |
| 56 | 友霖 | 1.5億 | -1.3% | -0.5% |
| 57 | 皇將 | 1.5億 | +100.8% | +34.8% |
| 58 | 晟德 | 1.4億 | +6.1% | -17.7% |
| 59 | 松瑞藥 | 1.4億 | +21.3% | +30.8% |
| 60 | 永鴻生技 | 1.3億 | +13.8% | +15.8% |
| 61 | 五鼎 | 1.3億 | -13.9% | -3.9% |
| 62 | 曜亞 | 1.3億 | +12.3% | +2.2% |
| 63 | 旭富 | 1.3億 | +30.4% | -19.8% |
| 64 | 逸達 | 1.3億 | +397.5% | +1,895.4% |
| 65 | 醫影 | 1.2億 | +107.1% | +5.5% |
| 66 | 青松健康 | 1.1億 | +17.0% | +3.1% |
| 67 | 濟生 | 1.1億 | +2.2% | -2.9% |
| 68 | 威力德生醫 | 1.1億 | +15.3% | -3.4% |
| 69 | 長聖 | 1.1億 | +0.8% | +1.5% |
| 70 | 奈米醫材 | 1.1億 | +15.2% | -4.9% |
| 71 | 豪展 | 1.1億 | +61.5% | +4.3% |
| 72 | 生泰 | 1億 | -24.5% | -24.0% |
| 73 | 高端疫苗 | 9,997.1万 | +43.2% | -51.7% |
| 74 | 明達醫 | 9,872.9万 | +12.3% | +17.2% |
| 75 | 永昕 | 9,796.7万 | +41.0% | -15.8% |
| 76 | 馬光-KY | 9,567.3万 | +7.3% | +6.0% |
| 77 | 達爾膚 | 9,534.8万 | +30.0% | +36.1% |
| 78 | 科懋 | 9,476.5万 | +32.6% | +24.1% |
| 79 | 中化生 | 9,461.4万 | +598.5% | +36.9% |
| 80 | 訊聯 | 9,439.2万 | -12.0% | -2.7% |
| 81 | 台聯電 | 8,778.5万 | +21.0% | +16.5% |
| 82 | 霈方 | 8,771万 | +57.7% | +23.4% |
| 83 | 鈺緯 | 8,571万 | +41.7% | +0.0% |
| 84 | 金萬林-創 | 8,322.9万 | +40.3% | -0.5% |
| 85 | 醫揚 | 8,294.1万 | -9.5% | -31.9% |
| 86 | 愛派司 | 8,112.4万 | +29.8% | +2.0% |
| 87 | 羅麗芬-KY | 7,826.7万 | +16.6% | +1.3% |
| 88 | 科妍 | 7,825.7万 | +1.6% | +28.1% |
| 89 | 和康生 | 7,437.3万 | +17.3% | -15.6% |
| 90 | 晉弘 | 7,265.8万 | +6.7% | +7.5% |
| 91 | 易威 | 6,771.9万 | +128.2% | -51.1% |
| 92 | 漢達 | 6,586.3万 | -24.8% | -6.5% |
| 93 | 正瀚-創 | 6,200.3万 | -26.4% | -47.6% |
| 94 | 泰宗 | 6,198.9万 | +10.2% | -0.6% |
| 95 | 達亞 | 5,376.1万 | -2.0% | -21.3% |
| 96 | 泰福-KY | 5,323.8万 | +13.7% | +67.1% |
| 97 | 立康 | 5,296.6万 | -8.1% | +26.4% |
| 98 | 中裕 | 5,243万 | +35.7% | -2.7% |
| 99 | 強生* | 5,005.2万 | -2.7% | +2.2% |
| 100 | 聿新科 | 4,814万 | -20.3% | +0.9% |
| 101 | 訊聯基因 | 4,717.8万 | +3.3% | -2.0% |
| 102 | 進階 | 4,628.6万 | -8.2% | -27.4% |
| 103 | 天良 | 4,409.6万 | +2.3% | -22.6% |
| 104 | 基米-創 | 4,244.9万 | -12.8% | -56.7% |
| 105 | 加捷生醫 | 4,207.3万 | +8.0% | -15.7% |
| 106 | 光麗-KY | 4,138.7万 | +53.0% | -23.4% |
| 107 | 常廣 | 4,117万 | -3.3% | -6.0% |
| 108 | 永日 | 4,005.1万 | +15.3% | +28.3% |
| 109 | 益安 | 3,795.5万 | +2.7% | -83.6% |
| 110 | 佰研 | 3,783.5万 | +125.2% | +5.8% |
| 111 | 長佳智能 | 3,669.1万 | -1.0% | -0.7% |
| 112 | ABC-KY | 3,578.9万 | +8.7% | -53.7% |
| 113 | 景岳 | 3,539.5万 | -4.1% | -22.3% |
| 114 | 威健生技 | 3,393.5万 | +22.2% | -4.5% |
| 115 | 永笙-KY | 3,304.6万 | +16.0% | +7.6% |
| 116 | 邦睿生技-創 | 3,220万 | +30.1% | +7.3% |
| 117 | 亞諾法 | 3,194万 | +19.1% | +30.8% |
| 118 | 慧智 | 3,017.5万 | -3.0% | -1.2% |
| 119 | 台微醫 | 2,969.5万 | +29.1% | +2.6% |
| 120 | 商之器 | 2,954.5万 | +184.8% | -6.0% |
| 121 | 智擎 | 2,253.3万 | -18.3% | -89.9% |
| 122 | 寶利徠 | 2,192.2万 | +0.6% | -2.0% |
| 123 | 博晟生醫 | 2,138.5万 | +24.8% | +0.0% |
| 124 | 浩泰 | 1,990万 | +34.9% | +20.3% |
| 125 | 合世 | 1,954.7万 | -42.3% | -29.0% |
| 126 | 樂斯科 | 1,950.4万 | +6.7% | -8.4% |
| 127 | 欣大健康 | 1,937.4万 | +26.3% | -8.7% |
| 128 | 上亞科技 | 1,779.8万 | +55.4% | +69.1% |
| 129 | 懷特 | 1,366.6万 | +6.0% | +15.3% |
| 130 | 福永生技 | 1,257.1万 | -72.1% | -63.3% |
| 131 | 台生材 | 1,235.3万 | -34.1% | -27.4% |
| 132 | 醣聯 | 1,186.2万 | — | — |
| 133 | 德英 | 1,160.2万 | -50.7% | +1.4% |
| 134 | 合一 | 1,113.9万 | +154.7% | +97.2% |
| 135 | 和迅 | 1,064.4万 | -59.8% | -36.4% |
| 136 | 共信-KY | 931.9万 | +397.3% | +221.7% |
| 137 | 雲象科技-創 | 575.2万 | -88.1% | -34.6% |
| 138 | 太景*-KY | 524.9万 | +60.2% | +66.6% |
| 139 | 海昌生技 | 474.6万 | -7.4% | -44.2% |
| 140 | 浩鼎 | 228.3万 | -58.7% | +40.8% |
| 141 | 沛爾生醫*-創 | 222.4万 | +3.2% | +15.2% |
| 142 | 安克 | 211.5万 | -16.6% | -6.3% |
| 143 | 杏國 | 201.3万 | -0.3% | -0.4% |
| 144 | 禾榮科 | 197.7万 | +42.2% | +78.9% |
| 145 | 北極星藥業-KY | 190万 | +894.8% | -69.9% |
| 146 | 國邑* | 157.9万 | — | -65.3% |
| 147 | 全福生技 | 147.4万 | +74.9% | +19.6% |
| 148 | 向榮生技 | 128.5万 | -44.4% | -48.7% |
| 149 | 浩宇生醫 | 56.4万 | -19.0% | -30.8% |
| 150 | 華安 | 38.6万 | -66.1% | -11.1% |
| 151 | 生華科 | 8万 | +0.0% | +0.0% |
| 152 | 順藥 | 7.8万 | -54.9% | -63.0% |
| 153 | 心誠鎂 | 4.4万 | -88.5% | -99.9% |
| 154 | 泰合 | 1万 | — | -99.2% |
| 155 | 益得 | 4,000 | -99.7% | -99.9% |
| 156 | 漢康-KY創 | 0 | — | — |
| 157 | 圓祥生技 | 0 | — | — |
| 158 | 康霈* | 0 | — | — |
| 159 | 台新藥 | 0 | — | — |
| 160 | 昱展新藥 | 0 | -100.0% | — |
出典:臺灣證券交易所「上市公司每月營業收入彙總表」(政府資料開放平臺)、證券櫃檯買賣中心「上櫃公司每月營業收入彙總表」(TPEx OpenAPI)、過去の月次は公開資訊觀測站(MOPS)。金額は台湾ドル。前年比・前月比は、このサイトが元の数値から計算。投資の判断を勧めるものではありません。更新日:2026-11-16